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Abstract - Protein electrostatics have been demonstrated 
to play a vital role in protein functionality, with many 
functionally important amino acid residues exhibiting an 
electrostatic state that is altered from that of a normal 
amino acid residue.  Residues with altered electrostatic 
states can be identified by the presence of a pKa value that 
is perturbed by 2 or more pK units, and such residues have 
been demonstrated to play critical roles in catalysis, 
ligand binding, and protein stability.  Within the HCV 
helicase and polymerase, as well as the HIV reverse 
transcriptase, highly conserved regions were demonstrated 
to possess a greater number and magnitude of 
perturbations than lesser conserved regions, suggesting 
that there is an interrelationship present between protein 
electrostatics and evolution. 
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1 Introduction 
   Rapid advances in the field of structural genomics 
have resulted in an increased demand for the development 
of techniques that can provide insights into the functions of 
proteins based on structural information.  Protein 
electrostatic states, facilitated by interactions between 
ionizable and polarizable groups, have been demonstrated 
to contribute to protein catalysis, ligand binding, protein 
stability, and protein solubility, as well as other aspects of 
protein function.  The Poisson-Boltzmann equation of 
continuum electrostatics provides a basis for the calculation 
of electrostatic interactions within proteins, and the finite 
difference forms of the equation, employed by program 
packages such as UHBD, APBS, DELPHI, and MEAD, 
allow for an atomic level of detail[1-4]. 
Recently, the electrostatic analysis of protein structures has 
been utilized to determine the protonation states and pKa 
values of ionizable amino acid residues within protein 
structures.  Calculations of amino acid protonation states 
across a range of pH values have been used to construct 
theoretical microscopic titration curves for amino acid 
residues within the proteins triose phosphate isomerase, 
aldose reductase, and phosphomannose isomerase.  For 
each of these proteins it was observed that residues within 
the active sites exhibited perturbed titration curves, in 
which the residues were partially protonated over a wide 
pH range.  These perturbed titration curves result in a 
perturbed pKa value for the residues, which, in turn, allows 
them to more readily contribute to an acid-base catalytic 
reaction.  The proton transfer involved in such reactions 
can occur most readily when the pKas of the donors and 
acceptors approach the reaction pH and as such 
electrostatic interactions are able to alter the residue pKas 
so that they approach the physiological pH of 7[5].  
Residues with pKa perturbations have been demonstrated 
to play a role in protein stability, such as in pyrrolydone 
carboxyl peptidases, where E192 was demonstrated to have 
a pKa value of ≥7.3.  This pKa perturbation allows E192 to 
remain protonated and form a stability contributing strong 
H-bond with the residue P162[6].  Moreover, residues with 
shifted pKa values have been observed in residues that 
contribute to the formation of protein-protein complexes, 
where 80% of acidic residues within complexes 
demonstrated a negative shift that helped to preserve their 
ionized state[7].  Furthermore, studies of the HCV NS3 
helicase have suggested that pKa perturbations also exist in 
residues that contribute to ligand binding, since within the 
RNA binding cleft of the protein E493 was observed to 
have a pKa value that was shifted in the positive direction, 
enabling the residue to remain neutrally charged and allow 
for improved coordination with DNA[8].   
Recent work involving the pKa calculation of 36,192 
ionizable residues located in 490 proteins revealed that 
about 35% of residues possessed a pKa value that was 
shifted by three or more pK units, and that these 
perturbations are more likely to occur in buried residues.  
The study also suggested that buried ionized residues were 
more likely to be conserved than ionized surface 
residues[9].  Comparisons between sequence entropy 
calculations and residue packing in a set of 130 proteins has 
suggested that tightly packed regions of protein structure 
are well conserved and that less densely packed regions 
exhibit lower levels of residue conservation.  The rationale 
behind this is that a protein structures ability to 
accommodate mutation is restrained by the available space 
within the structure to accommodate the mutation, and 
hence more densely packed structures have less space and 
hence less ability to accommodate a mutation[10].  
 
While the relationship between pKa perturbations and 
residue conservation is of great interest to the study of all 
proteins, there are direct clinical applications for such a 
relationship in the development of antiviral and 
antimicrobial drug treatments.  Both RNA viruses and 
retroviruses have been demonstrated to rapidly develop 
antiviral mutations when exposed to drug therapy, since 
these types of viruses lack the ability to proofread during 
nucleic acid synthesis.  It is hypothesized that within 
Hepatitis C Virus (HCV) and HIV that there will exist a 
relationship between residue conservation and pKa 
perturbation, and that many of these perturbed residues will 
be of functional significance.  This study will examine this 
relationship within the HCV NS3 helicase and the NS5B 
polymerase, as well as the HIV reverse transcriptase (RT).  
Within the HIV RT the study will further examine the 
relationship between pKa perturbations and antiviral 
mutations, in order to better examine the role of 
electrostatics in systems of evolutionary selective pressure. 
 
2 Methods 
2.1 Structure Selection 
 Structures were selected for each of the proteins 
examined in this work based on the criteria that one 
structure exists in the native conformation of the protein 
and is not bound to any non-native ligands (e.g. an antiviral 
drug).  If available, a structure bound to each native 
ligands, however, was selected since it was determined that 
perturbations are only induced in certain residues in the 
presence of bound ligand[8].  In cases where multiple 
crystal structures of the unbound or ligand bound states 
were available only one was selected for analysis.  This 
determination was made because of the computationally 
intensive nature of the pKa calculation, and the similarity of 
results found between different crystal structures 
representative of the same conformation that were 
computed during trial runs.   
 
HCV helicase 
 The HCV helicase structures used in this study 
include the 8OHM structure, which is representative of the 
non-ligand bound form of the enzyme.  The 1A1V structure 
contains a short segment of bound deoxyuracil, which was 
modified to deoxycytosine to facilitate recognition by the 
H++ program.  Both the 8OHM and 1A1V structures 
consist of a truncated form of the protein that contains only 
the helicase region, but lacks the protease region.  The third 
helicase structure considered was the 1CU1 structure which 
consists of the full length form of the enzyme (helicase and 
protease regions).  This structure is a dimer, but 
calculations were performed on an individual subunit.   
 
HCV polymerase 
 The HCV polymerase structures utilized in the study 
include the 1NB4 structure, which is representative of the 
polymerase in the absence of ligands.  The 1NB6 structure 
is a UTP bound form of the polymerase and the 1NB7 
structure consists of the polymerase bound to a short RNA 
strand.  The selenomethionine residues in each structure 
were modified to methionine to facilitate recognition by the 
H++ program.   
 
HIV reverse transcriptase 
The HIV reverse transcriptase structures analyzed 
included the 1RTJ structure, which is representative of a 
non-ligand bound form of the enzyme.  The 2HMI structure 
was also analyzed, which consists of the polymerase bound 
to a double stranded DNA segment.  In both cases the 
structures are dimers consisting of p66 and p50 subunits 
and electrostatic calculations were performed on the dimers 
since the dimers are shown to be the biologically active 
form of the enzyme.    
 
2.2 Calculation of pKas 
 pKa values were calculated using the H++ Web 
Server, available at http://biophysics.cs.vt.edu/H++ [11].  
This Web server begins the pKa prediction by adding 
missing atoms and assigning partial charges to the 
uploaded protien structure using the PROTONATE and 
LEAP modules of the AMBER molecular modelling 
system and the parm99 force field[12].  The positions of 
these added protons are then optimized using 100 steps of 
conjugate gradient descent minimization and 500 steps of 
Molecular Dynamics simulation at 300K.  Protein 
electrostatic calculations are then performed using the 
Poisson-Boltzman equation in the program package 
MEAD, and used to compute the free energies of the 
protonation microstates[2].  Titration curves and pKa 
values are then determined using the clustering approach 
described by Gilson[13]. 
2.3 Calculation of ∆pKa 
 ∆pKas were calculated by taking the calculated pKa 
of a given residue and subtracting from it the typical pKa 
of a residue of that type (Asp=3.65, Glu=4.25, His=6.0, 
Tyr=10.06, Lys 10.52, and Arg=12.48).  The absolute 
value of the result of this subtraction was then taken.  
These steps were repeated for each residue of a given 
enzyme type and the largest ∆pKa value of a given residue 
across all structures of that enzyme type was selected as the 
maximum ∆pKa for that residue.  The rationale behind this 
is that different perturbation states are often observed 
between ligand bound and non-ligand bound forms of the 
enzyme.  Thus taking the maximum pKa observed in any 
structure is most likely to ensure that the residue is 
considered in its most electrostatically significant state.  
For the HIV reverse transcriptase, the p50 subunit is a 
truncated form of the p66 subunit.  Thus the maximum 
∆pKa was determined based on the maximum value 
achieved in any subunit in either of the structures 
examined.  The rationale behind this is that residues may 
not be of equal significance in each subunit conformation 
and this method ensures that the most electrostatically 
significant form of the residue is considered during later 
residue conservation comparisons. 
2.4 Determination of Sequence Entropy 
 Sequence entropy is a measure of relative 
conservation that takes into account both the frequency and 
variety of amino acids observed in each position and 
entropy calculations were performed using the Entropy-
ONE Web application available from the HCV Sequence 
Database Website (http://hcv.lanl.gov/content/hcv-
db/ENTROPY/entropy_one.html).  Aligned sequences for 
the HCV NS3 helicase (156 sequence) and HCV NS5B 
polymerase (149 sequences) were obtained from the 
database and used to calculate the entropy score associated 
with each residue position.  A set of 400 HIV-1 sequences 
was obtained from the HIV Sequence Database 
(http://www.hiv.lanl.gov/content/hiv-db/mainpage.html) 
and used to compute the associated entropy scores. 
2.5 Statistical Analysis 
 All plots and statistical analyses were performed in 
Graph-Pad Prism version 4.01.   
 
3 Results 
3.1 Residue Perturbations 
 Many of the perturbed residues in each of the three 
proteins have been previously characterized as being 
crucial to the function of the protein.  For example, within 
the HCV helicase the pKa of E490 was shifted upwards by 
4.8 pK units, which would mean that the residue would be 
neutrally rather than negatively charged at physiological 
pH.  This pertubation has been demonstrated to be essential 
for the coordination of DNA with E493 within the HCV 
helicase, since it makes residue interaction with negatively 
charged DNA possible[8].  Likewise in the HCV 
polymerase D318 and D319 exhibit downward 
perturbations by 3.1 and 4.9 pK units, respectively, which 
ensure that the residues always remained within their 
negatively charged state.  Since these residues are involved 
with the coordination of Mg2+ ions, these pertubations are 
consistant with their functionality[14].  Within the HIV 
RT, similar perturbations are observed in residues D185 
and D186, which displayed upward pKa shifts of up to 8.8 
and 12.6 pK units respectively.  These residues have been 
demonstrated to be involved in the coordination of 
DNA/RNA and these perturbations would mean that the 
aspartate residues would be neutrally charged at 
physiological pH and hence better able to coordinate with 
DNA[15].  These findings are thereby consistant with 
previous studies that indicate a correlation between residue 
functionality and residue perturbation. 
 
3.2 Relationship Between Perturbation and 
Conservation 
  For each of the proteins invesitigated in this study, 
plots of ∆pKa versus residue conservation demonstrate that 
the greatest numbers of perturbed residues are found in low 
entropy (highly conserved) regions of the proteins.  
Furthermore, the better conserved residues also exhibited 
peturbations of greater magnitude than lesser conserved 
residues (Figure 1). 
 Fig. 1. Plot of the magnitudes of residue 
perturbations versus the entropy scores associated 
with the reside positions.  
The significance of these observations was assessed by 
dividing the residues into three categories, based on their 
respective entropy scores.  Highly conserved residues were 
residues with an entropy score of less than 0.1, whereas 
moderately conserved residues were residues with an 
entropy score greater than 0.1 but less than 0.4.  All 
residues with an entropy score greater than 0.4 were 
considered poorly conserved.  These groups were created 
by examining the distribution of residues in Figure 1and 
dividing the residues into three approximately equal 
groupings.  The fraction of peturbed residues present in 
each group was then computed (Figure 2) and the Kruskal-
Wallis test used to determine that the three groups are 
statistically significant (P<0.0001). 
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3.3 Effects of Drug Resistance 
 The relationship between drug resistance and protein 
electrostatics was examined by compiling a list of all 
known mutations in ionizable residues that confer drug 
resistance and examining the perturbation states of these 
residues (Table 1). Currently out of the 57 residue 
positions whose mutation has been shown to lead to 
resistance, there are 11 such mutations in ionizable residues 
(HIV Sequence Database), and only three of these 
mutations occur in residues without perturbed pKas.  Given 
the relationship between residue perturbation and 
functionality these findings are suggestive that the 
evolution of resistance mutations may alter protein 
functionality (e.g. ligand binding) via the selected mutation 
of functionally significant residues. 
 Table 1. Positions of ionizable residues and their associated perturbations 
and entropy scores 
Residue Resistance Type ∆pKa Entropy Reference 
E44 3TC 2.09 0.031 Montes, 2002 
K65 3TC 10.32 0.079 Bazmi, 2000 
D67 AZT 9.56 0.161 Imamichi, 2000
K70 AZT 1.23 0.213 Kellam, 1992 Fig. 2. Fraction of perturbed residues present at each
level of residue conservation. he average maximum perturbation magnitude was then 
omputed for each group (Figure 3) and a one-way 
NOVA used to determine that each group is statistically 
ignificant (P<0.0001).  These results are indicative that 
here is a relationship between electrostatic perturbation 
nd residue conservation, which is likely due to the 
unctional significance of residue perturbation.   
 
E89 PFA 5.41 0.035 Tachedjian, 1995 
K101 AZT + atevirdine 10.52 0.035 Demeter, 1998 
K103 atevirdine 2.21 0.091 Demeter, 1998 
E138 TSAO 2.23 0.143 Van Laethem, 2000 
R211 AZT + 3TC 0.385 1.166 Kemp, 1998 
K219 AZT 2.84 0.134 Kellam, 1992 
K238 AZT + atevirdine 0.251 0.251 Demeter, 1998 
 Fig. 3. Average magnitude of residue perturbation present
at each level of residue conservation. 
4 Discussion 
 The results of this study demonstrate that for the HIV 
reverse transcriptase and the HCV helicase and polymerase 
there is an association between residue perturbation and 
residue conservation.  This association is supported in that 
perturbations have been demonstrated in numerous studies 
to correlate to functionally important elements of a given 
protein and previous findings that indicate that functionally 
important residues tend to exhibit a high degree of 
conservation.  These findings also further suggest that 
protein physics and evolution are highly intertwined.  The 
intramolecular electrostatic interactions of the protein are 
what account for the presence of these perturbations, and 
contribute to protein functionality, yet evolution plays a 
role in the maintenance of these perturbations since the 
conditions of tight residue packing that enable such 
interactions are entropicly unfavorable, and would not 
otherwise be maintained without the presence of some 
biological advantage.   
 
This inter-relationship between physics and evolution also 
raises some interesting possibilities when one considers the 
apparently outlying points on the plots shown in figure 1.  
Within the plots there are several points that exhibit 
significant electrostatic perturbations (>2 pK units) but are 
not well-conserved residues.  While there is the possibility 
of these being the result of calculation errors since pKa 
calculation software is not always accurate[16], there is 
also the potential for such residues to be agents of 
evolutionary change.  Since residue perturbations are 
demonstrated to have functional impact on a protein 
structure it is a likely possibility that the residue variant 
present in the crystal structure is having some form of 
functional impact on the protein structure in question, 
where functional impact could include possibilities such as 
a change in catalytic rate, binding affinity, or stability.  If 
they have a positive functional effect it is likely that such 
residues may become conserved over evolutionary time and 
if they have a deleterious effect it is likely they will 
disappear over the course of evolutionary time.  It would 
thus make an interesting avenue of future study to examine 
the fate of such residues over successive generations of any 
rapidly replicating organism.   
 
While the above conjecture may explain a possible general 
mechanism by which the functionality of a given protein 
can enhance/adapt its suitability to its environment over 
evolutionary time, the drug resistance data provides a 
glimpse at evolution in the face of selective pressure.  Drug 
resistance mutations generally seek to reduce the protein’s 
capacity for binding the drug and in doing so often reduce 
the protein’s ability to bind its native ligand as well 
resulting in reduced enzyme fidelity and/or activity.  Since 
8 out of 11 drug resistance mutations of ionizable residues 
occurred in perturbed positions, it suggests that the 
evolution of drug resistance mutations targets residues of 
functional significance.  This is supported by findings, 
which indicate that several of the drug resistance residue 
positions have been characterized as being functionally 
significant.  The mutation of E44 to an aspartate has been 
demonstrated to cause a decrease in viral load, indicating 
that the enzyme functionality is reduced by the mutation of 
this position[17].  Furthermore, K65 has been demonstrated 
to have a role in nucleotide binding specificity[18] and 
K103 has been demonstrated to be critical to the transition 
of the unliganded nucleotide binding pocket from its closed 
to its open state[19].  It would be of great interest if future 
studies could be utilized to determine if mutation of 
functionally significant residues is limited to the 
development of drug resistance or is a characteristic 
common amongst multiple cases of evolution under 
selective pressure.   
 
Moreover, the conservation of perturbed residues observed 
in the absence of selective pressure indicates that these 
perturbations and their associated functionality are also 
likely conserved, and this may likely form the basis of the 
some of the common functional motifs that are observed.  
For example, in the DEXH ATP binding motif of the HCV 
helicase, which is analogous  to the DEAD box binding 
motif and has been previously demonstrated to have 
functionaly significant perturbations[8], component 
residues have strong electrostatic interactions with each 
other that contribute to these perturbations, according to the 
residue interaction data generated by the H++ program.  It 
was also observed throughout the data set, that many of the 
residues which strongly interacted with perturbed residues 
were also highly conserved, suggesting that the 
functionality provided by many residues may be to help 
provide a proper electrostatic environment for the 
maintanence of functionaly significant perturbations.  
Whether such electrostatic perturbation and interaction 
motifs are conserved over evolutonary time remains to be 
shown.   
 
In all, the findings of this study are indicative that an 
intricate relationship exists between protein physics and 
evolution, but that future studies are needed to better define 
this relationship and the mechanisms under which it 
operates.  Once understood, however, knowledge of this 
relationship could be used to not only enhance our 
understading of protein evolution, but could also likely 
provide the basis for powerful tools for protein engineering 
and de novo protein design.   
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